pmid,title,journal,year,drug,disease
40501515,Ruxolitinib Is an Effective Therapy for Ciltacabtagene Autoleucel-Associated Parkinsonism in Multiple Myeloma.,Journal of hematology,2025,Ruxolitinib,Parkinson's
28969943,Deciphering the pathways that protect from IL-13-mediated potentiation of oxidative stress-induced dopaminergic nerve cell death.,Cytokine,2018,Ruxolitinib,Parkinson's
